Literature DB >> 1325825

Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.

E J Derbyshire1, R V Henry, R A Stahel, E J Wawrzynczak.   

Abstract

The cytotoxic activity profile of an immunotoxin, SWA11-ricin A chain, recognising a cell-surface antigen associated with human small cell lung cancer (SCLC), was examined in detail using a panel of SCLC, non-SCLC and non lung tumour cell lines in tissue culture. SWA11-ricin A chain was potently and selectively active against three SCLC cell lines of both classic and variant morphologies, inhibiting the incorporation of 3H-leucine with an IC50 of 5 x 10(-11) M. At a concentration of 1 x 10(-8) M, the SWA11 immunotoxin could selectively eliminate in excess of 99.9% of clonogenic tumour cells. Intoxication proceeded rapidly following a 4 h lag phase; the initial rate of protein synthesis inhibition occurred with a t50 of 2 h and a t10 of 7 h. The cytotoxic activity of SWA11-ricin A chain was potentiated by 100-fold in the presence of the carboxylic ionophore monensin at 1 x 10(-7) M. Kinetic studies revealed that monensin enhanced the rate of protein synthesis inhibition by two-fold and eliminated the lag phase suggesting a rapid effect on either the rate or route of internalisation. Studies with SWA11 could detect no influence of monensin on the rate of antibody internalisation and a transient delay in the delivery of internalised antibody to lysosomes was observed by immunoelectron microscopy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325825      PMCID: PMC1977953          DOI: 10.1038/bjc.1992.294

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

Review 1.  Immunotoxins in the therapy of leukemias and lymphomas.

Authors:  A A Hertler; A E Frankel
Journal:  Cancer Invest       Date:  1991       Impact factor: 2.176

2.  Antigenic modulation by anti-CD5 immunotoxins.

Authors:  J M Manske; D J Buchsbaum; S M Azemove; D E Hanna; D A Vallera
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

Review 3.  Innovative and future approaches to small cell lung cancer treatment.

Authors:  L K Beck; M A Kane; P A Bunn
Journal:  Semin Oncol       Date:  1988-06       Impact factor: 4.929

4.  Establishment and identification of small cell lung cancer cell lines having classic and variant features.

Authors:  D N Carney; A F Gazdar; G Bepler; J G Guccion; P J Marangos; T W Moody; M H Zweig; J D Minna
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

5.  Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins.

Authors:  M J Bjorn; D Ring; A Frankel
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

6.  Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.

Authors:  M J Embleton; V S Byers; H M Lee; P Scannon; N W Blackhall; R W Baldwin
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

7.  Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin.

Authors:  D Carrière; P Casellas; G Richer; P Gros; F K Jansen
Journal:  Exp Cell Res       Date:  1985-02       Impact factor: 3.905

8.  Two small cell lung cancer cell lines established from rigid bronchoscope biopsies.

Authors:  P E Postmus; L de Ley; A Y van der Veen; G Mesander; C H Buys; J D Elema
Journal:  Eur J Cancer Clin Oncol       Date:  1988-04

9.  Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival.

Authors:  C M Tsai; D C Ihde; C Kadoyama; D Venzon; A F Gazdar
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

10.  Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.

Authors:  E J Wawrzynczak; E J Derbyshire; R V Henry; G D Parnell; A Smith; R Waibel; R A Stahel
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more
  8 in total

Review 1.  Immunotoxins to human small-cell lung cancer.

Authors:  E J Wawrzynczak; E J Derbyshire
Journal:  Cell Biophys       Date:  1992 Aug-Dec

2.  Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.

Authors:  E J Derbyshire; R A Stahel; E J Wawrzynczak
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 3.  Are There Any Other Compounds Isolated From Dermacoccus spp at All?

Authors:  Manaf AlMatar; Mohamed Eldeeb; Essam A Makky; Fatih Köksal; Işıl Var; Begüm Kayar
Journal:  Curr Microbiol       Date:  2016-10-26       Impact factor: 2.188

4.  Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanine-proline.

Authors:  E Weber; H P Lehmann; A G Beck-Sickinger; E J Wawrzynczak; R Waibel; G Folkers; R A Stahel
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

5.  The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.

Authors:  Y Olabiran; J A Ledermann; N J Marston; G M Boxer; R Hicks; R L Souhami; S G Spiro; R A Stahel
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

6.  Immunotoxin Therapy for Lung Cancer.

Authors:  Li-Yi Xie; Hai-Lan Piao; Min Fan; Zhen Zhang; Chen Wang; Darell D Bigner; Xu-Hui Bao
Journal:  Chin Med J (Engl)       Date:  2017-03-05       Impact factor: 2.628

7.  Cytotoxicity, Apoptosis, Migration Inhibition, and Autophagy-Induced by Crude Ricin from Ricinus communis Seeds in A549 Lung Cancer Cell Lines.

Authors:  Irma Erika Herawati; Ronny Lesmana; Jutti Levita; Anas Subarnas
Journal:  Med Sci Monit Basic Res       Date:  2022-07-07

8.  Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.

Authors:  E J Derbyshire; L de Leij; E J Wawrzynczak
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.